Teva Revives Patent Fight After FDA OKs Lilly's Migraine Drug
Hours after a Massachusetts federal judge said Teva Pharmaceuticals couldn't sue Eli Lilly & Co. for infringing patents tied to a migraine biologic because Lilly's version lacked U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article